Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (21-30 of 499) with videos related to

Pageof 50
Sort By:
Oncology (Williston Park, N.Y.)|December 25, 2007
Clinical research of EGFR inhibitors and related dermatologic toxicitiesRoman Perez-Soler, Eric Van Cutsem
Best Practice & Research. Clinical Gastroenterology|March 5, 2009
Acute and long-term gastrointestinal consequences of chemotherapyFrédéric Di Fiore, Eric Van Cutsem
Oncology|November 23, 2005
Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancerAimery de Gramont, Eric Van Cutsem
Clinical Colorectal Cancer|June 20, 2015
Unraveling the Complexities of Treating Metastatic Colorectal Cancer With Angiogenesis InhibitorsKaren Overstreet, Eric Van Cutsem, Monique Johnson
The Lancet. Oncology|November 28, 2009
Improved first-line chemotherapy: a better chance for surgery?Sabine Tejpar, Eric Van Cutsem, Rene Adam
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
New strategies for treatment of KRAS mutant metastatic colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Impact of molecular markers on treatment selection in advanced colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
Targeted Oncology|May 7, 2013
Role of targeted agents in metastatic colorectal cancerHans Prenen, Loredana Vecchione, Eric Van Cutsem
Best Practice & Research. Clinical Gastroenterology|April 24, 2002
The treatment of advanced colorectal cancer: where are we now and where do we go?Eric Van Cutsem, Chris Verslype, Ingrid Demedts
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 30, 2003
The role of chemotherapy in the current treatment of gastric cancerEric Van Cutsem, Daniel Haller, Atsushi Ohtsu
Pageof 50

Showing results (21-30 of 499) with videos related to

Sort By:
Pageof 50
Oncology (Williston Park, N.Y.)|December 25, 2007
Clinical research of EGFR inhibitors and related dermatologic toxicitiesRoman Perez-Soler, Eric Van Cutsem
Best Practice & Research. Clinical Gastroenterology|March 5, 2009
Acute and long-term gastrointestinal consequences of chemotherapyFrédéric Di Fiore, Eric Van Cutsem
Oncology|November 23, 2005
Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancerAimery de Gramont, Eric Van Cutsem
Clinical Colorectal Cancer|June 20, 2015
Unraveling the Complexities of Treating Metastatic Colorectal Cancer With Angiogenesis InhibitorsKaren Overstreet, Eric Van Cutsem, Monique Johnson
The Lancet. Oncology|November 28, 2009
Improved first-line chemotherapy: a better chance for surgery?Sabine Tejpar, Eric Van Cutsem, Rene Adam
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
New strategies for treatment of KRAS mutant metastatic colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Impact of molecular markers on treatment selection in advanced colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
Targeted Oncology|May 7, 2013
Role of targeted agents in metastatic colorectal cancerHans Prenen, Loredana Vecchione, Eric Van Cutsem
Best Practice & Research. Clinical Gastroenterology|April 24, 2002
The treatment of advanced colorectal cancer: where are we now and where do we go?Eric Van Cutsem, Chris Verslype, Ingrid Demedts
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 30, 2003
The role of chemotherapy in the current treatment of gastric cancerEric Van Cutsem, Daniel Haller, Atsushi Ohtsu
Pageof 50